Can primaquine therapy for vivax malaria be improved?

Can primaquine therapy for vivax malaria be improved?

The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...

書誌詳細
主要な著者:	Baird, J, Rieckmann, K
フォーマット:	Journal article
言語:	English
出版事項:	2003

類似資料

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
著者:: Baird, J
出版事項: (2018)

Primaquine as anti-relapse therapy for Plasmodium vivax
著者:: Baird, J
出版事項: (1998)

Primaquine therapy for malaria.
著者:: Baird, J, 等
出版事項: (2004)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
著者:: Krudsood, S, 等
出版事項: (2008)

Treatment of primaquine-resistant Plasmodium vivax malaria.
著者:: Luzzi, G, 等
出版事項: (1992)

TREATMENT OF PRIMAQUINE-RESISTANT PLASMODIUM-VIVAX MALARIA
著者:: Luzzi, G, 等
出版事項: (1992)

Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
著者:: Fryauff, D, 等
出版事項: (1995)

Primaquine for plasmodium vivax malaria treatment – authors' reply
著者:: Price, RN, 等
出版事項: (2020)

Primaquine in vivax malaria: an update and review on management issues
著者:: Fernando Deepika, 等
出版事項: (2011-12-01)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
著者:: Pavani Reddy, 等
出版事項: (2006-11-01)

Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
著者:: Sutanto, I, 等
出版事項: (2013)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
著者:: Walter R J Taylor, 等
出版事項: (2021-09-01)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
著者:: Watson, J, 等
出版事項: (2019)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
著者:: Taylor, WRJ, 等
出版事項: (2021)

Reinventing primaquine for endemic malaria.
著者:: Baird, J
出版事項: (2012)

Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar.
著者:: Yuan, L, 等
出版事項: (2014)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
著者:: Setyadi, A, 等
出版事項: (2019)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
著者:: Llanos-Cuentas, A, 等
出版事項: (2019)

Consideration of ethics in primaquine therapy against malaria transmission.
著者:: Baird, J, 等
出版事項: (2011)

Consideration of ethics in primaquine therapy against malaria transmission
著者:: Baird, J, 等
出版事項: (2011)

Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
著者:: Watson, JA, 等
出版事項: (2022)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
著者:: Pukrittayakamee, S, 等
出版事項: (1994)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
著者:: Agus Setyadi, 等
出版事項: (2019-04-01)

Artesdiaquine and Primaquine combined treatment is more effective for Malaria vivax
著者:: Santoso Santoso
出版事項: (2012-07-01)

Primaquine for prevention of malaria in travelers.
著者:: Baird, J, 等
出版事項: (2003)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
著者:: A. Taylor Bright, 等
出版事項: (2013-05-01)

Rational malaria chemoprophylaxis - the position of primaquine
著者:: Baird, J
出版事項: (2017)

Determinants of primaquine and carboxyprimaquine exposures in children and adults with Plasmodium vivax malaria
著者:: Chu, CS, 等
出版事項: (2021)

Mass primaquine treatment to eliminate vivax malaria: Lessons from the past
著者:: Kondrashin, A, 等
出版事項: (2014)

Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria.
著者:: Bright, A, 等
出版事項: (2013)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
著者:: Baird, J, 等
出版事項: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
著者:: James Watson, 等
出版事項: (2018-04-01)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
著者:: Watson, J, 等
出版事項: (2018)

Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria
著者:: Chu, C, 等
出版事項: (2018)

Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria
著者:: Chu, C, 等
出版事項: (2018)

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
著者:: Baird, J, 等
出版事項: (1995)

Absence of gender influence on the pharmacokinetics of chloroquine combined with primaquine in malaria vivax patients
著者:: Michelle Valeria Dias Ferreira Vieira, 等
出版事項: (2020-10-01)

Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin
著者:: Amanda Gabryelle Nunes Cardoso Mello, 等
出版事項: (2018-10-01)

Therapeutic efficacy of chloroquine and primaquine for <it>Plasmodium vivax</it> malaria treatment in southeast Iran
著者:: Heidari Aliehsan, 等
出版事項: (2012-10-01)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
著者:: Taylor, WR, 等
出版事項: (2021)